Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Mach

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Eclinicalmedicine|December 24, 2025
Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trialEdna Omar Viegas, Emilia Fumane, Kassia Pereira, et al.
MMWR. Morbidity and Mortality Weekly Report|July 17, 2020
Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019Grace Macklin, Ousmane M Diop, Asghar Humayun, et al.
The Lancet Regional Health. Western Pacific|January 11, 2024
Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021William Pomat, Rocio Lopez Cavestany, Visalakshi Jeyaseelan, et al.
The Journal of Infectious Diseases|March 15, 2019
Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in VietnamDang Thi Thanh Huyen, Ondrej Mach, Nguyen Thanh Trung, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2014
Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013Mohamed A Sheikh, Frederick Makokha, Abdullahi M Hussein, et al.
The Journal of Infectious Diseases|October 16, 2014
Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in BangladeshHossain M S Sazzad, Jeanette J Rainey, Anna-Lea Kahn, et al.
The Journal of Infectious Diseases|October 16, 2014
Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009Ondrej Mach, Harish Verma, Devendra W Khandait, et al.
Vaccine|February 23, 2025
Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in CubaSonia Resik, Rocio Lopez Cavestany, Alina Tejeda, et al.
The Lancet. Infectious Diseases|October 14, 2021
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in AfricaLaura V Cooper, Ananda S Bandyopadhyay, Nicksy Gumede, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trialYamin Wang, Qing Xu, Vishali Jeyaseelan, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Eclinicalmedicine|December 24, 2025
Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trialEdna Omar Viegas, Emilia Fumane, Kassia Pereira, et al.
MMWR. Morbidity and Mortality Weekly Report|July 17, 2020
Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019Grace Macklin, Ousmane M Diop, Asghar Humayun, et al.
The Lancet Regional Health. Western Pacific|January 11, 2024
Poliovirus serological assay after the cVDPV1 outbreak in Papua New Guinea: a cross-sectional study from 2020 to 2021William Pomat, Rocio Lopez Cavestany, Visalakshi Jeyaseelan, et al.
The Journal of Infectious Diseases|March 15, 2019
Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in VietnamDang Thi Thanh Huyen, Ondrej Mach, Nguyen Thanh Trung, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2014
Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013Mohamed A Sheikh, Frederick Makokha, Abdullahi M Hussein, et al.
The Journal of Infectious Diseases|October 16, 2014
Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in BangladeshHossain M S Sazzad, Jeanette J Rainey, Anna-Lea Kahn, et al.
The Journal of Infectious Diseases|October 16, 2014
Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009Ondrej Mach, Harish Verma, Devendra W Khandait, et al.
Vaccine|February 23, 2025
Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in CubaSonia Resik, Rocio Lopez Cavestany, Alina Tejeda, et al.
The Lancet. Infectious Diseases|October 14, 2021
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in AfricaLaura V Cooper, Ananda S Bandyopadhyay, Nicksy Gumede, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trialYamin Wang, Qing Xu, Vishali Jeyaseelan, et al.
Pageof 7